O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×

Agile Gurugram 2022 - Manoj Jain | Are retrospectives worth the time and effort?

Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio

Confira estes a seguir

1 de 18 Anúncio
Anúncio

Mais Conteúdo rRelacionado

Mais de AgileNetwork (20)

Mais recentes (20)

Anúncio

Agile Gurugram 2022 - Manoj Jain | Are retrospectives worth the time and effort?

  1. 1. Manoj Jain Senior Director – Software Engineering Oct 30, 2022 RETROSPECTIVES ARE WE REALLY GETTING BENEFITTED FROM THEM? agilegurugram.com
  2. 2. 2 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted ABOUT ME • Hands-on quality engineer since 1999 • Leading quality engineering at Axtria • Previously worked with Mezocliq, Oracle, MakeMyTrip, CA Technologies, Nucleus Software & Newgen Software • Speaker & author • Cyclist • Philanthropist Manoj.jain@axtria.com manojjain99@yahoo.com https://www.linkedin.com/in/manojjain/ https://twitter.com/manojjain99
  3. 3. 3 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted AXTRIA – DRIVING LIFE SCIENCES INDUSTRY PERFORMANCE THROUGH UNIQUE LS-FOCUSED COMBINATION OF DECISION SCIENCE, COMMERCIAL EXCELLENCE & DATA MANAGEMENT Employees Worldwide 2,900+ Principals with 20+ years of Life Sciences experience Locations Global Delivery and Data Centers 80+ 19 • Enterprise Technology Platform • Cloud-based Configurable IP • Deep Pharma experience • Strategic & Operational Expertise • Cloud Data Management • Cloud BI & Insights • Cloud MDM • Big Data • Territory Alignment • Call Planning • Incentive Compensation • Field Reporting • Sales & Marketing Analytics • OTC Analytics • Patient Analytics • Digital Analytics • NBA • Omnichannel Orchestration • Customer Journey DECISION SCIENCE & COMMERCIAL EXCELLENCE PHARMA DATA MANAGEMENT & TECHNOLOGY Clients including 8 of Top 10 Pharma & 15 of Top 20 Pharma Commercial Ops sales reps on Axtria’s platform 100+ 100,000+ Driving PERFORMANCE for our Clients Through Transformational DECISION SCIENCE & COMMERCIAL EXCELLENCE Powered by Extensive Pharma DATA MANAGEMENT & TECHNOLOGY Expertise Global Presence
  4. 4. 4 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted HOW MANY OF US FIND RETROSPECTIVES EFFECTIVE? How many of us are 100% getting benefitted from retrospectives? How many of us are conducting retrospective meetings consistently?
  5. 5. 5 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted TIME FOR REALITY CHECK…
  6. 6. 6 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted ARE WE ALONE FACING THIS? AVAILABILITY OF LITERATURE CONFIRMS THAT WE’RE NOT JUST ALONE
  7. 7. HOW DID WE ADDRESS IT?
  8. 8. 8 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted 5 BEST PRACTICES FOR BETTER OUTCOME
  9. 9. 9 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted PARTICIPATION AND NOT JUST ATTENDANCE
  10. 10. 10 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted MEETING NOTES - LEVERAGING JIRA FOR TRACKING ITEMS Status wise summary of all action items Owner wise summary of action items List of all OPEN action items and their owners Status of all action items in swim lanes for better visibility Adding retrospective action items to sprint backlog is quite effective.
  11. 11. 11 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted OWNERSHIP - CATEGORIZING FEEDBACKS & TASK FORCES
  12. 12. 12 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted AVOIDING REPEATING ISSUES • DONENESS criteria not being met • Capacity planning and scheduling not done properly • Requirements were not ready at start of the sprint Focus on automation of processes or guard-rails instead of manual reviews
  13. 13. 13 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted AN EXAMPLE OF AUTOMATION…
  14. 14. 14 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted FOLLOW-UP…FOLLOW-UP…FOLLOW-UP… • Absolute clarity about owner(s) for each action item/task force with ETA • Dedicating 15mins in every sprint review meeting for update on retrospective action items • If it is important, then it deserves dedicated time & effort
  15. 15. 15 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted OUTCOME? 100% participation of team & not just attendance 50% reduction of recurring issues 20% improvement in sprints’ velocity 80% stories meeting DONENESS criteria (from 50%) 25% reduction in sprint spill overs
  16. 16. 16 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted KEY TAKEAWAYS 1. Track action items with owners and ETAs 2. Don’t try to boil the ocean but focus on 1-2 high impact areas a time 3. Don’t give-up irrespective of results and change course of action, if required
  17. 17. 17 Copyright © 2021 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential – Internal/Restricted/Highly Restricted QUESTIONS?
  18. 18. Do you have a question for us?

×